About Centro Integral de Reumatologia del Caribe SAS CIRCARIBE SAS
Clinical Trials at Centro Integral de Reumatologia del Caribe SAS CIRCARIBE SAS
During the past decade, Centro Integral de Reumatologia del Caribe SAS CIRCARIBE SAS conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on
average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centro Integral de Reumatologia del Caribe SAS CIRCARIBE SAS" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Genentech, Inc." with 2 trials
sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Galapagos NV" with 1 trials sponsored and "Hoffmann-La Roche"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Integral de Reumatologia del Caribe SAS CIRCARIBE SAS"
#1 collaborator was "Incyte Corporation" with 2 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Centro Integral de Reumatologia del Caribe SAS CIRCARIBE SAS
According to Clinical.Site data, the most researched conditions in "Centro Integral de Reumatologia del Caribe SAS CIRCARIBE SAS" are
"Systemic Lupus Erythematosus" (3 trials), "Rheumatoid Arthritis" (2 trials), "Lupus Erythematosus, Systemic" (1 trials) and "Lupus Nephritis" (1 trials). Many other conditions were trialed in "Centro Integral de Reumatologia del Caribe SAS CIRCARIBE SAS" in a lesser frequency.
Clinical Trials Intervention Types at Centro Integral de Reumatologia del Caribe SAS CIRCARIBE SAS
Most popular intervention types in "Centro Integral de Reumatologia del Caribe SAS CIRCARIBE SAS" are "Drug" (7 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Baricitinib" (2 trials), "GDC-0853" (2 trials), "Anti-TNF-alpha" (1 trials) and "BMS-188667" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centro Integral de Reumatologia del Caribe SAS CIRCARIBE SAS
The vast majority of trials in "Centro Integral de Reumatologia del Caribe SAS CIRCARIBE SAS" are
7 trials for "All" genders.
Clinical Trials Status at Centro Integral de Reumatologia del Caribe SAS CIRCARIBE SAS
Currently, there are NaN active trials in "Centro Integral de Reumatologia del Caribe SAS CIRCARIBE SAS".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Centro Integral de Reumatologia del Caribe SAS CIRCARIBE SAS,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Centro Integral de Reumatologia del Caribe SAS CIRCARIBE SAS, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".